Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34: 1056–83., , , et al.
Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update. A Scientific Statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36: 916–23., , , &
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349: 1569–81.
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997; 349: 1641–9.
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355: 1205–10., , , &
Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke 2002; 33: 2722–7., , &
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl.): 483S–512S. http://www.chestjournal.org/cgi/reprint/126/3_suppl/483S., , , , &
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41., , , et al.
Contrast-enhanced MR angiography for carotid disease: diagnostic and potential clinical impact. Neurology 2004; 62: 1282–90., , , et al.
Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208–16., , , , , &
Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001; 57: 2000–5., , , et al.
Long-term mortality in cerebrovascular disease. Stroke 2003; 34: 699–704., , , , , &
Incidence and outcome of subtypes of ischaemic stroke: initial results from the North East Melbourne stroke incidence study (NEMESIS). Cerebrovasc. Dis. 2003; 15: 133–9., , , , , &
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995; 333: 1581–7.
Early stroke treatment associated with better outcome: the National Institute of Neurological Disorders and Stroke rt-PA stroke study. Neurology 2000; 55: 1649–55., , , et al.
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1997; 28: 2119–25.
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286: 2830–8., , , et al.
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004; 35: 904–11.
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and National Institute of Neurological Disorders and Stroke rt-PA stroke trials. Lancet 2004; 363: 768–74., , , et al.
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432–8., , , et al.
Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333–7., , , , &
Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann. Neurol. 2003; 54: 66–74., , , , &
Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569–73., , &
Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280–4., , , et al.
for the Stroke–Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N. Engl. J. Med. 2006; 354: 588–600., , , et al.
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43., , &
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006; 37: 577–617., , , et al.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000; 342: 145–53., , , , , &
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–97.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–39., , , et al.
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565–75., , , et al.
A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 2001; 345: 1243–9., , , , , &
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12., , , et al.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33., , , et al.
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 1996; 143: 1–13., , , , , &
The ESPS Group. The European Stroke Prevention Study (ESPS): principal end-points. Lancet 1987; 2: 1351–4.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–39.
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331–7., , , et al.
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med. 2006; 354: 1706–17., , , et al.
Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann. Intern. Med. 2003; 138: 831–8., , , et al.
Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst. Rev. 2004(4): CD000187. &
Cardioembolic stroke: an update. Lancet Neurol. 2003; 2: 177–88.
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 1994; 331: 1474–9., , , et al.
Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF transesophageal echocardiogram Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am. J. Cardiol. 1999; 83: 453–5, A9., , , et al.
Anticoagulation for stroke prevention: yes, no, maybe. Cleve. Clin. J. Med. 2004; 71 (Suppl. 1): S52–6.
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625–31., , , , &
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 2005; 352: 1305–16., , , et al.
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N. Engl. J. Med. 2001; 345: 1444–51., , , et al.
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576–84., , , et al.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–72., , , et al.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003., , , et al.
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534–44., , , et al.
Decision-making for carotid endarterectomy: the trials are only the start. Can. J. Neurol. Sci. 2002; 29: 302–4.
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 1998; 339: 1415–25., , , et al.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–8.
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–502., , , et al.
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 2004; 351: 1493–501., , , et al.
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915–24., , , , &
Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855–61., , , , &
Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 2003; 34: 2290–301., , &
The carotid occlusion surgery study. Neurosurg. Focus 2003; 14 (3): e9., , , , &
Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280: 1055–60., , , et al.
Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30: 593–8., , , , &
Small centrum ovale infarcts on diffusion-weighted magnetic resonance imaging. Stroke 2002; 33: 1541–4., , , , &
Clinical neuromythology VI. Au clair de lacune: holy, wholly, holey logic. Neurology 1989; 39: 725–30.
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465–71., , , et al.
Multisection computed tomography angiography compared with catheter angiography in diagnosing vertebral artery dissection. AJNR Am. J. Neuroradiol. 2004; 25: 769–74., , , , &
Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003; 61: 1347–51., , , , , &
Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology 2000; 55: 1172–9., , &
Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1042–50., , , et al.
Transient ischemic attack: proposal for a new definition. N. Engl. J. Med. 2002; 347: 1713–16., , , et al.
Short-term prognosis after emergency department diagnosis of transient ischemic attack. JAMA 2000; 284: 2901–6., , , &
Validation of a 4-point prediction rule to stratify short-term stroke risk after transient ischemic attack [abstract]. Stroke 2005; 36: 430. [Presentation, International Stroke Meeting, February 2006.] &
Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 2001; 344: 1450–60., , , , , &
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365: 387–97., , , et al.
Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905–15., , , et al.
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1–5., , , et al.
Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 2005; 352: 777–85., , , et al.
Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987–93., , , , &
The intracerebral hemorrhage score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32: 891–7., , , , &
Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 2315–28., , et al.
International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002; 360: 1267–74., , , et al.
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005; 36: 1011–15., , , et al.
Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology 1993; 43: 712–18., , , &
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J. Neurosurg. 1990; 73: 37–47., , , , &
International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N. Engl. J. Med. 1998; 339: 1725–33.
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003; 362: 103–10., , , et al.
Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc. Dis. 2004; 17 (Suppl. 2): 1–14., , , et al.
European Stroke Initiative Recommendations for Stroke Management: update 2003. Cerebrovasc. Dis. 2003; 16: 311–37., , , et al.
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke 2005; 36: 690–703., , , et al.
Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst. Rev. 2002 (1): CD000197.
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 283: 3102–9., , , et al.
Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36: e100–43., , , et al..
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000; 343: 180–4., , , , , &
Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 553–8., , , et al.
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–34., , , et al.
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early computed tomography Score. Lancet 2000; 355: 1670–4., , , &
Quantitative assessment of the time course of infarct signal intensity on diffusion-weighted images. AJNR Am. J. Neuroradiol. 2003; 24: 680–7., , , , &
Intracranial hemorrhage: principles of computed tomography and magnetic resonance imaging interpretation. Eur. Radiol. 2001; 11: 1770–83., , , , , &
Cerebrovascular Ultrasound in Stroke Prevention and Treatment: Elmsford, NY; Oxford: Blackwell/Futura, 2004.
Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol. Sci. 2001; 22: 353–6., , , , &
Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc. Dis. 2000; 10: 490–6. &
Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 2002; 33: 670–4. &
Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol. Scand. 2002; 106: 84–92., , , , , &
Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. JAMA 1968; 205: 337–40.
Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2: 81–4. &
Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J. Neurosurg. 1968; 28: 14–20. &
A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J. Neurol. Neurosurg. Psychiatry 1988; 51: 1457., , , et al.
Cerebral vascular accidents in patients over the age of 60. Scott. Med. J. 1957; 2: 200–15.
Modification of Rankin scale: recovery of motor function after stroke. Stroke 1988; 19: 1497–500. &
Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7., , , , &
Interrater reliability of the National Institutes of Health stroke scale. Arch. Neurol. 1989; 46: 660–2., , &
National Institutes of Health Stroke Scale training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446–9., , , et al.